HealthOn review

The public figures describe different parts of the offer rather than a verified single checkout total. The semaglutide product page starts at $189 and the tirzepatide page at $290; a general weight-loss banner starts at $155 per month. Product explanations describe monthly billing with corresponding shipping and quarterly billing with shipments every three months. Separately, advertised savings of up to $408 for semaglutide or $375 for tirzepatide refer to twelve-month plans and carry an upfront-payment footnote. That does not establish the exact discount or final charge for every patient. The cancellation policy adds another distinction by describing prepaid three-, six- and twelve-month plans while also saying patients can pay monthly and receive medicine in advance. Selected first-month and renewal amounts were not filled in on the public product view, which also displayed Out of Stock. Obtain the actual available offer, total due now, future debits, medication quantity and discount conditions in writing. Do not assume the $155 banner matches the $189 product or multiply either starting figure into a confirmed annual bill. No selected invoice or stock allocation was reviewed, so this review keeps the final price unconfirmed.

The detailed policy requires 30 days' written notice and says billing and services continue until cancellation becomes effective. Dashboard flexibility therefore should not be read as an immediate stop to every pending charge. The dedicated cancellation policy says a subsequent renewal or shipment may occur up to three days early; the terms use two days. Ask which processing date governs your order and act before it rather than assuming the nominal renewal date remains the last opportunity. A provider-ordered shipment cannot simply be canceled, and medication already dispensed or shipped is nonrefundable. The policy promises a cancellation confirmation within five business days; retain the written request and the confirmation stating the effective date. A documented medical exception may waive the notice period after review, and approved early termination can prorate program fees while excluding medication. If HealthOn cannot fulfill future refills because of regulatory restrictions or supply problems, the policy separately provides for unused-month proration and allows declining an alternative treatment. Those conditional remedies are not a general promise to refund a voluntary early exit from a prepaid term. Clarify what remains payable for medication already supplied in advance before deciding how flexible a particular plan really is.

No. Medication is nonrefundable, and the terms limit eligible reimbursement to membership fees. The guarantee also has substantial entry, participation and claim conditions. It applies to qualifying new enrollments after its August 2024 enrollment cutoff, requires 180 days of active participation and an initial BMI of at least 30, and uses weight loss below 5% as its outcome threshold. Participants must complete medical forms and labs within five days, use medication weekly, log weight and document 150 minutes of weekly exercise. The policy excludes returning members and early cancellations, requires that no sixth-month refill be requested, and limits requests to days 181–210. The terms' additional verification section calls for timestamped video and Healthie attestation and describes reimbursement processing within 30 days after verification. Confirm the complete applicable requirements before relying on the offer; the participation and documentation rules affect whether a request is eligible at all. A guarantee is a financial policy, not independent evidence that treatment will produce a particular result. It does not establish that a participant can recover six months of medication spending, receive an automatic refund at six months or skip clinical review. Ask for the eligible membership-fee amount separately from drug and other charges in the selected plan.

The terms distinguish Healthon Inc., the platform, from Healthon Medical Group Inc. and other possible clinical groups, as well as independent pharmacies and laboratories. Those roles should remain separate when evaluating the service: the company taking an enrollment is not necessarily the medical practice or dispensing facility. The telehealth consent describes choosing a pharmacy through support, but the material reviewed did not identify the pharmacy assigned to a selected GLP-1 prescription. Request the actual practice, treating clinician, pharmacy name and dispensing address, then confirm the relevant state authorization for your location. This review did not establish a current individual license, patient assignment or batch certificate. There is also a relevant historical marketing issue: the FDA's September 2025 letter identifies Healthon Inc. dba Healthon and concerns misleading approval, equivalence and efficacy claims for compounded semaglutide and tirzepatide. It is an identified company letter, not a patient-specific finding about today's vial. Current product disclaimers distinguish compounded medicine from FDA-approved drugs, but do not establish formal case closeout or independent product testing. Neither platform identity nor a disclaimer substitutes for the dispensing information and instructions attached to your own prescription.

The public care descriptions are broader than an itemized benefit schedule. HealthOn advertises virtual visits, ongoing oversight and secure provider messaging, and its FAQ describes state-dependent video visits and unlimited messaging if medication is prescribed. Those statements do not settle the number of live follow-ups, the interval between appointments or how quickly a clinician will answer a dose or side-effect question. The advertised 24/7 access should not be treated as guaranteed immediate care. For labs, the terms say that services ordered through the platform use its Labs and that the cost is part of the purchased total. That does not prove every GLP-1 plan funds a standard patient bloodwork panel, collection fees or repeat testing. Ask what your clinician requires, whether outside results are accepted and what the quoted total actually includes. Likewise, obtain a supply list covering syringes, swabs and disposal, plus instructions matched to the medication concentration. A multidisciplinary support description does not establish a particular dietitian allowance or a dedicated professional for every message. Finally, clarify payment method: legal cash-pay and no-insurance language differs from the homepage's softer insurance descriptions. These details determine the care and out-of-pocket costs available under your specific purchase.

The public product view displayed Out of Stock while also showing subscription choices and starting prices. That leaves the selected offer's availability unresolved; it does not prove that every HealthOn treatment or every patient's refill is unavailable. Ask which medication, quantity and plan can actually be supplied before paying. A complete current GLP-1 state list was not established either. The terms require the consultation location to match the shipping state, and the FAQ describes state-dependent video visits. Confirm eligibility for your actual physical location, including a move or travel that could affect the consultation. Timing also needs context: product badges advertise free shipping in 1–2 days, while the homepage FAQ describes delivery in a few business days after prescription review and dispensing, with processing and location variation. Neither is a guaranteed signup-to-door interval. Establish when clinical review occurs, when the pharmacy prepares the prescription and what transit estimate applies after dispatch. If refills cannot be supplied, ask about the policy's alternative-treatment or unused-month refund provisions. Those provisions exclude medication already dispensed or shipped, so the stage of fulfillment matters as much as the general availability banner. Obtain storage and delivery-problem instructions from the actual dispenser.